Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

Novo Nordisk

Status: Completed

Conditions: Haemostasis; Haemophilia B; Congenital Bleeding Disorder

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT02568202

U1111-1171-8168 (Other Identifier)

HAEM-4268

Details and patient eligibility

About

This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).

Enrollment: 449 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults aged below or equal to 18 years with hemophilia B (any severity, with or without inhibitors)
• Caregivers of children currently aged below 18 years with hemophilia B (any severity, with or without inhibitors)
• Subjects must have access to the internet, either at home or at a location convenient to them
• Provision of informed consent before the start of any survey-related activities

Exclusion criteria

• Inability to understand and comply with written instructions in English
• Previous completion of the B-HERO-S study with receipt of compensation
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Trial design

449 participants in 1 patient group

Survey

Treatment:

Other: No treatment given